Litton Mark James (CIK 1604834) reported 6 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-03-05). Recent activity: Buy LONA (22,254 shares), Sell LONA (5,156 shares), Buy ATHA (10,834 shares), Sell ATHA (2,586 shares), Buy ATHA (108,334 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-05 | LeonaBio, Inc. (LONA) | PRESIDENT and CEO | Buy | 22,254 | $0 |
| 2026-03-05 | LeonaBio, Inc. (LONA) | PRESIDENT and CEO | Sell | 5,156 | $27,688 |
| 2026-01-05 | Athira Pharma, Inc. (ATHA) | President and CEO | Buy | 10,834 | $0 |
| 2026-01-05 | Athira Pharma, Inc. (ATHA) | President and CEO | Sell | 2,586 | $17,792 |
| 2025-07-02 | Athira Pharma, Inc. (ATHA) | President and CEO | Buy | 108,334 | $0 |
| 2025-07-02 | Athira Pharma, Inc. (ATHA) | President and CEO | Sell | 25,123 | $7,286 |
Source: SEC Form 4 filings · as of 2026-03-05